Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype

Cancer Detection and Prevention

Volumn 30, Issue 2, 2006, Pages 111-117

  Mylona, Eleni E ^a   Alexandrou, Paraskevi Th ^a   Giannopoulou, Ioanna A ^a   Rafailidis, Petros I ^a   Markaki, Sofia ^b   Keramopoulos, Antonios ^b   Nakopoulou, Lydia L ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ALEXANDRA HOSPITAL   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Breast cancer; Disease free survival; Estrogen receptors; Ets 1; Histologic grade; Histologic type; Immunohistochemistry; Lymph nodes; Menopausal status; MMP 7; Nuclear grade; p53; Patient survival; Prognosticators; Stage; Topoisomerase II ; Tumor phenotype; uPAR

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ESTROGEN RECEPTOR; MATRILYSIN; PROGESTERONE RECEPTOR; PROTEIN P53; TRANSCRIPTION FACTOR ETS 1; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST HYPERPLASIA; CANCER CELL; CANCER DIAGNOSIS; CANCER GRADING; CANCER IMMUNOLOGY; CANCER SURVIVAL; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; PROTO-ONCOGENE PROTEIN C-ETS-1; SURVIVAL ANALYSIS;

EID: 33646888652     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2006.03.006     Document Type: Article

References (38)

1. Leprince D., Gegonne A., Coll J., de Taisne C., Schneeberger A., and Stehelin D. A putative second cell-derived oncogene on avidin leukemia retrovirus E26. Nature 306 (1983) 345-347
2. Oikawa T., and Yamada T. Molecular biology of the Ets family of transcription factors. Gene 303 (2003) 11-34
3. Graves B.J., and Petersen J.M. Specificity within the ets family of transcription factors. Adv Cancer Res 75 (1998) 1-55
4. Sharrocks A.D. The ETS-domain transcription factor family. Nat Rev Mol Biol 2 (2001) 827-837
5. Edwards D.H., Rocheleau H., Sharma R.R., Wills A.J., Cowle A., Hassell J.A., et al. Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription. Biochim Biophys Acta 1171 (1992) 41-55
6. Goldberg G., Frisch S., He C., Wilhelm S., Reich R., and Collier I. Secreted proteases. Regulation of their activity and their possible role in metastasis. Ann NY Acad Sci 580 (1990) 375-384
7. Kitange G., Shibata S., Tokunaga Y., Yagi N., Yasunaga A., Kishikawa M., et al. Ets-1 transcription factor-mediated urokinase type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors. Lab Invest 79 (1999) 407-416
8. Stephens R., Brunner N., Janicke F., and Schmitt M. The urokinase plasminogen activator system as a target for prognostic studies in breast cancer. Breast Cancer Res Treat 52 (1998) 99-111
9. Ito T., Nakayama T., Ito M., Naito S., Kanematsu T., and Sekine I. Expression of ets-1 proto-oncogene in human pancreatic carcinoma. Mod Pathol 11 (1998) 209-215
10. Nakayama T., Ito M., Ohtsuru A., Naito S., Nakashima M., and Sekine I. Expression of ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion. Am J Pathol 149 (1996) 1931-1939
11. Nakayama T., Ito M., Ohtsuru A., Naito S., Nakashima M., and Sekine I. Expression of the ets-1 proto-oncogene in human thyroid tumor. Mod Pathol 12 (1999) 61-68
12. Soni S., Pande P., Shukla N.K., and Ralhan R. Coexpression of Ets-1 and p53 in oral carcinomas is associated with P-glycoprotein expression and poor prognosis. J Cancer Res Clin Oncol 128 (2002) 336-342
13. Tsutsumi S., Kuwano H., Asao T., Nagashima K., Shimura T., and Mochiki E. Expression of ets-1 angiogenesis-related protein in gastric cancer. Cancer Lett 160 (2000) 45-50
14. Bolon I., Gouyer V., Deroassoux V., Vandenbunder B., Wernert N., Moro D., et al. Expression of c-ets-1, collagenase-1 and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 147 (1995) 1298
15. Trojanowska M. Ets factors and regulation of the extracellular matrix. Oncogene 19 (2000) 6464-6471
16. Wernert N., Gilles F., Fateur V., Bouali F., Raes M.B., Pyke C., et al. Stromal expression of c-ets-1 transcription factor correlates with tumor invasion. Cancer Res 54 (1994) 5683-5688
17. Barrett I.M., Pugila M.A., Singh G., and Tozer R. Expression of ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells. Breast Cancer Res Treat 72 (2002) 227-232
18. Behrens P., Rothe M., Wellmann A., Krischler J., and Wernert N. The ets-1 transcription factor is up-regulated together with MMP-1 and MMP-9 in the stroma of pre-invasive breast cancer. J Pathol 194 (2001) 43-50
19. Kurpios N.A., Sabolic N.A., Shepherd T.G., Fidalgo G.M., and Hassell J.A. Function of PEA3 ets transcription factors in mammary gland development and oncogenesis. J Mam Gland Biol Neoplasia 8 (2003) 177-190
20. Span P.N., Manders P., Heuvel J.J., Thomas C.M., Bosch R.R., Beex L.V., et al. Expression of the transcription factor ets-1 is an independent prognostic marker for relapse free survival in breast cancer. Oncogene 21 (2002) 8506-8509
21. Association of Directors of Anatomic and Surgical Pathology. Recommendations for file reporting of breast carcinoma. Hum Pathol 1996; 27:220-224.
22. Elston C.W. Grading of invasive carcinoma of the breast. In: Page D.L., and Anderson T.J. (Eds). Diagnostic histopathology of the breast (1987), Churchill Livingstone, Edinburgh 300-311
23. Rosen P.P. Intraductal carcinoma in Rosen's breast pathology (1997), Lippincott-Raven, Philadelphia p. 279-81
24. Hermanek P, Sobin LH, International Union against Cancer. TNM classification of malignant tumors. 4th ed., 2nd rev. Berlin: Springer-Verlag; 1992.
25. Nakopoulou L., Lazaris A.C., Kavantzas N., Alexandrou P., Athanassiadou P., Keramopoulos A., et al. DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer. Pathobiology 68 (2000) 137-143
26. Mylona E., Kapranou A., Mavrommatis J., Markaki S., Keramopoulos A., and Nakopoulou L. The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer. APMIS 113 (2005) 246-255
27. McClelland R.A., Wilson D., Leake R., Finlay P., and Nicholson R.I. A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. Eur J cancer 27 (1991) 711-716
28. Nakayama T., Ito M., Otsuru A., Naito S., and Sekine I. Expression of the ets-1 proto-oncogene in human colorectal carcinoma. Mod Pathol 14 (2001) 415-422
29. Prognonec P, Boulukos KE, Ghysdall J. The c-ets-1 protein in chromatin associated and binds to DNA in vitro. Oncogene 1989; 4: 691-697.
30. Pharoch P.D., Day N.E., and Caldas C. Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer 80 (1999) 1968-1973
31. Gasco M., Shami S., and Crook T. The p53 pathway in breast cancer. Breast Cancer Res 4 (2002) 70-76
32. Nakopoulou L., Alexiadou A., Theodoropoulos G.E., Lazaris A., Tzonou A., and Keramopoulos A. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer. J Pathol 179 (1996) 31-38
33. Venanzoni M.C., Robinson L.R., Hodge D.R., Kola I., and Seth A. Ets-1 and ets-2 in p53 regulation: spatial separation of ets binding site (EBS) modulate protein-DNA interaction. Oncogene 12 (1996) 1199-1204
34. Kanda K., Nakayama T., Onizuka S., Tomioka T., and Kanematsu T. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma. Hepatogastroenterology 49 (2002) 747-751
35. Matrisian L.M. Matrix metalloproteinase gene expression. Ann NY Acad Sci 91 (1994) 10129-10133
36. Ozaki I., Mizuta T., Zhao G., Yotsumoto H., Hara T., Kajihara S., et al. Involvement of the ets-1 gene in overexpression of Matrilysin in human hepatocellular carcinoma. Cancer Res 60 (2000) 6519-6525
37. Sasaki H., Yukiue H., Moiriyama S., Kobayashi Y., Nakashima Y., Kaji M., et al. Clinical significance of matrix metalloproteinase-7 and ets-1 gene expression in patients with lung cancer. J Surg Res 101 (2001) 242-247
38. Davidson B., Reich R., Goldberg I., Gotlieb W.H., Kopolovic J., Berner A., et al. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin Cancer Res 7 (2001) 551-557